Carl M. Cohen

1.3k total citations
28 papers, 1.1k citations indexed

About

Carl M. Cohen is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carl M. Cohen has authored 28 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Carl M. Cohen's work include Erythrocyte Function and Pathophysiology (23 papers), Blood properties and coagulation (13 papers) and Lipid Membrane Structure and Behavior (7 papers). Carl M. Cohen is often cited by papers focused on Erythrocyte Function and Pathophysiology (23 papers), Blood properties and coagulation (13 papers) and Lipid Membrane Structure and Behavior (7 papers). Carl M. Cohen collaborates with scholars based in United States, Pakistan and Australia. Carl M. Cohen's co-authors include Catherine Korsgren, Susan F. Foley, Daniel Branton, Robert C. Langley, Luanne L. Peters, A. K. Solomon, Samuel E. Lux, Linda R. Adkison, Bruce S. Jacobson and Pamela L. Jackson and has published in prestigious journals such as Nature, Cell and Journal of Clinical Investigation.

In The Last Decade

Carl M. Cohen

28 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl M. Cohen United States 18 685 557 386 383 101 28 1.1k
Catherine Korsgren United States 16 741 1.1× 373 0.7× 276 0.7× 397 1.0× 142 1.4× 20 983
Hervé Barrière Canada 16 117 0.2× 799 1.4× 352 0.9× 385 1.0× 65 0.6× 17 1.3k
Sinikka Eskelinen Finland 19 120 0.2× 564 1.0× 228 0.6× 63 0.2× 103 1.0× 49 896
Thomas G. Easton United States 10 107 0.2× 435 0.8× 132 0.3× 80 0.2× 47 0.5× 10 907
John Anagli United States 21 81 0.1× 603 1.1× 387 1.0× 40 0.1× 53 0.5× 31 1.0k
Patrick L. Williamson United States 8 157 0.2× 416 0.7× 88 0.2× 37 0.1× 38 0.4× 9 651
Salvatore Cortellino United States 13 293 0.4× 600 1.1× 291 0.8× 43 0.1× 36 0.4× 20 1.1k
Gaëlle Pennarun France 14 150 0.2× 745 1.3× 63 0.2× 164 0.4× 40 0.4× 18 1.0k
Iris Schvartz Israel 17 219 0.3× 423 0.8× 74 0.2× 48 0.1× 49 0.5× 26 896
Venugopal D. Talkad United States 13 228 0.3× 660 1.2× 275 0.7× 23 0.1× 106 1.0× 14 1.0k

Countries citing papers authored by Carl M. Cohen

Since Specialization
Citations

This map shows the geographic impact of Carl M. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl M. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl M. Cohen more than expected).

Fields of papers citing papers by Carl M. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl M. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl M. Cohen. The network helps show where Carl M. Cohen may publish in the future.

Co-authorship network of co-authors of Carl M. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Carl M. Cohen. A scholar is included among the top collaborators of Carl M. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl M. Cohen. Carl M. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peters, Luanne L., Babette Gwynn, Kathryn M. John, et al.. (1999). Mild spherocytosis and altered red cell ion transport in protein 4.2–null mice. Journal of Clinical Investigation. 103(11). 1527–1537. 65 indexed citations
2.
Gwynn, Babette, et al.. (1997). The Gene Encoding Protein 4.2 Is Distinct from the Mouse Platelet Storage Pool Deficiency Mutation Pallid. Genomics. 42(3). 532–535. 13 indexed citations
3.
Korsgren, Catherine, et al.. (1996). Role ofN-Myristylation in Targeting of Band 4.2 (Pallidin) in Nonerythroid Cells. Experimental Cell Research. 229(2). 421–431. 7 indexed citations
4.
Misra, Suniti, et al.. (1995). Phosphatidylinositol 3-Kinase Activity in Murine Erythroleukemia Cells during DMSO-Induced Differentiation. Experimental Cell Research. 219(2). 454–460. 16 indexed citations
5.
Speicher, David W., et al.. (1993). Structural domain mapping and phosphorylation of human erythrocyte pallidin (band 4.2). Biochimica et Biophysica Acta (BBA) - Biomembranes. 1148(1). 19–29. 11 indexed citations
6.
Gascard, Philippe, Tadeusz Pawełczyk, John M. Lowenstein, & Carl M. Cohen. (1993). The role of inositol phospholipids in the association of band 4.1 with the human erythrocyte membrane. European Journal of Biochemistry. 211(3). 671–681. 29 indexed citations
7.
Peters, Luanne L., et al.. (1992). The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene. Nature Genetics. 2(1). 80–83. 74 indexed citations
8.
Cohen, Carl M., et al.. (1990). Cellular and molecular biology of normal and abnormal erythroid membranes : proceedings of a UCLA Colloquium held at Taos, New Mexico, February 3-10, 1989. 1 indexed citations
9.
Cohen, Carl M., et al.. (1989). Wheat germ agglutinin but not concanavalin A modulates protein kinase C‐mediated phosphorylation of red cell skeletal proteins. FEBS Letters. 257(2). 431–434. 20 indexed citations
10.
Langley, Robert C. & Carl M. Cohen. (1987). Cell type‐specific association between two types of spectrin and two types of intermediate filaments. Cell Motility and the Cytoskeleton. 8(2). 165–173. 32 indexed citations
11.
Cohen, Carl M.. (1986). Cell biology: Origins of the cytoskeleton. Nature. 321(6065). 18–19. 1 indexed citations
12.
Langley, Robert C. & Carl M. Cohen. (1986). Association of spectrin with desmin intermediate filaments. Journal of Cellular Biochemistry. 30(2). 101–109. 53 indexed citations
13.
Dainiak, Nicholas & Carl M. Cohen. (1985). Regulation of Human Erythroid Proliferation in Vitro by Leukocyte Surface Componentsa. Annals of the New York Academy of Sciences. 459(1). 129–142. 8 indexed citations
14.
Cohen, Carl M. & Susan F. Foley. (1984). Biochemical characterization of complex formation by human erythrocyte spectrin, protein 4.1, and actin. Biochemistry. 23(25). 6091–6098. 63 indexed citations
15.
Cohen, Carl M. & Robert C. Langley. (1984). Functional characterization of human erythrocyte spectrin .alpha. and .beta. chains: association with actin and erythrocyte protein 4.1. Biochemistry. 23(19). 4488–4495. 50 indexed citations
16.
Cohen, Carl M., Ruth M. Kramer, & Daniel Branton. (1980). Transbilayer mapping of membrane proteins using membranes isolated on polylysine-coated polyacrylamide beads. Biochimica et Biophysica Acta (BBA) - Biomembranes. 597(1). 29–40. 10 indexed citations
17.
Cohen, Carl M.. (1980). Spectrin-actin associations studied by electron microscopy of shadowed preparations. Cell. 21(3). 875–883. 149 indexed citations
18.
Cohen, Carl M. & Catherine Korsgren. (1980). Band 4.1 causes spectrin-actin gels to become thixiotropic. Biochemical and Biophysical Research Communications. 97(4). 1429–1435. 80 indexed citations
19.
Cohen, Carl M. & A. K. Solomon. (1976). Ca binding to the human red cell membrane: Characterization of membrane preparations and binding sites. The Journal of Membrane Biology. 29(1). 345–372. 37 indexed citations
20.
Cohen, Carl M., et al.. (1969). Cytotoxicity of lens antisera to dissociated chick neural retina cells in tissue culture. Development. 21(3). 391–406. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026